Oxford, United Kingdom

Yichen Li

This inventor holds 1 USPTO granted patent. Top assignee: University of Southern California. Active years: 2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yichen Li. Retrieved from https://idiyas.com/inventor/yichen-li-0hjuwqwh

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2020

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yichen Li: Innovator in Neurological Disease Treatment

Introduction

Yichen Li is a prominent inventor based in Oxford, GB. He has made significant contributions to the field of neurological disease treatment. His innovative approach focuses on methods to address conditions associated with altered C9ORF72 protein activity.

Latest Patents

Yichen Li holds 1 patent for his groundbreaking work titled "Methods to treat neurological diseases." This patent discloses a method for treating subjects with neurological diseases by administering an effective dose of a pharmaceutical composition. The method aims to rescue defects linked to altered C9ORF72 protein activity. Additionally, it describes methods for identifying compounds that can inhibit motor neuron degeneration.

Career Highlights

Yichen Li is affiliated with the University of Southern California, where he continues to advance research in neurological treatments. His work has garnered attention for its potential to improve the lives of individuals suffering from neurological disorders.

Collaborations

Yichen Li collaborates with notable colleagues, including Yingxiao Shi and Justin K Ichida. Their combined expertise enhances the research efforts in the field of neurological diseases.

Conclusion

Yichen Li's innovative methods for treating neurological diseases represent a significant advancement in medical research. His contributions have the potential to make a lasting impact on the treatment of neurological conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…